SignalHF vs eMurmur Heart AI
AI Verdict
Choose SignalHF if…
Choose SignalHF if your primary objective is to proactively prevent heart failure hospitalizations in patients with existing cardiac implantable electronic devices (CIEDs). This FDA-cleared AI algorithm specializes in analyzing diverse CIED data to predict 30-day hospitalization risk, enabling early intervention and personalized care plans for high-risk individuals.
View SignalHF →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if you require an efficient, AI-powered platform for automated heart and lung sound analysis, especially for detecting and classifying murmurs. This tool is ideal for broad screening, monitoring, and remote consultation across various healthcare settings, offering hemodynamic insights and supporting both digital stethoscopes and mobile platforms.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SignalHF | eMurmur Heart AI |
|---|---|---|
| Pricing | Contact for pricing | Contact for quote |
| Deployment | SaaS | Web-based, Mobile App, API integration |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers a broader range of user interaction and accessibility with its mobile app, web portal, live streaming, and remote auscultation capabilities, making it highly versatile for various clinical settings. SignalHF, while efficient for CIED data management, is more focused on a specific workflow, giving eMurmur an edge in overall user flexibility and access.
Clinical Value
SignalHFSignalHF provides a more direct and impactful clinical value by predicting heart failure hospitalizations within 30 days, enabling early intervention and personalized care to prevent critical events. While eMurmur Heart AI offers valuable diagnostic support for murmurs, SignalHF's predictive capability for a major clinical outcome has a potentially greater impact on patient outcomes and healthcare costs.
Pricing & Value
TieBoth tools require direct contact for pricing information, and neither provides publicly available details on their pricing structure or specific cost-saving benefits. Without this crucial information, it is not possible to conduct a comparative assessment of their value propositions.
Enterprise Readiness
SignalHFSignalHF stands out for its ability to centralize and standardize cardiac implantable device data from various manufacturers into a single platform. This manufacturer-agnostic approach is a significant advantage for large healthcare enterprises managing diverse CIED populations, streamlining complex data management.
Innovation
SignalHFSignalHF demonstrates greater innovation by utilizing an FDA-cleared AI algorithm for predictive analytics, anticipating heart failure hospitalizations based on complex, multi-manufacturer CIED data. This proactive, preventative approach to patient management represents a more advanced application of AI compared to eMurmur's diagnostic assistance.
Support & Docs
SignalHFImplicity, the company behind SignalHF, explicitly details a comprehensive 'Customer Success team' that provides onboarding, training, ongoing support, and activity reviews. This structured approach to customer assistance and readily available 'instructions for use' indicates a more robust support and documentation framework than what is publicly available for CSD Labs' eMurmur Heart AI.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SignalHF | eMurmur Heart AI |
|---|---|---|
| Name | SignalHF | eMurmur Heart AI |
| Company | Implicity | CSD Labs |
| Description | FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care. | FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings. |
| Key Features | FDA-cleared AI algorithm for heart failure prediction, Predicts heart failure hospitalizations within 30 days, Manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs), Analyzes physiological data, demographics, lead measurements, episodes, and therapies, Generates automatic alerts for care teams based on risk scores, Enables early intervention and personalized care plans, Unified platform for centralizing cardiac implantable device data, AI-driven alert management to filter and highlight relevant events | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights (loudness ratios of S1, systole, S2, diastole), Mobile app (iOS, Android) and web portal for access, Hardware-neutral and stethoscope agnostic platform compatibility, Live streaming and remote auscultation for telehealth, Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring |
| Specialties | Cardiology | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring SignalHF and eMurmur Heart AI.